Afternoon NZ,
I remember mention of ELANCO's patent over the MPL compound expiring 2024.
If PAA have patented it for use in neurodegenerative disease, does the expiry have any bearing on PAA?
I remember comments are needing to wait until had expired?
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow), page-65
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 19.0¢ | $35.68K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 313313 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 18199 | 2 |
View Market Depth
| Last trade - 13.02pm 14/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |